MARTELLI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 2.563
EU - Europa 1.308
AS - Asia 287
OC - Oceania 24
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.199
Nazione #
US - Stati Uniti d'America 2.555
RU - Federazione Russa 442
IE - Irlanda 221
SE - Svezia 211
PL - Polonia 134
HK - Hong Kong 96
IT - Italia 89
SG - Singapore 79
DE - Germania 59
CN - Cina 56
FI - Finlandia 44
UA - Ucraina 43
IN - India 34
GB - Regno Unito 32
AU - Australia 24
BE - Belgio 15
CI - Costa d'Avorio 11
TR - Turchia 11
CA - Canada 8
RO - Romania 7
JO - Giordania 6
NL - Olanda 4
MU - Mauritius 3
DZ - Algeria 2
VN - Vietnam 2
BG - Bulgaria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
FR - Francia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
KH - Cambogia 1
KR - Corea 1
LT - Lituania 1
Totale 4.199
Città #
Santa Clara 900
Chandler 237
Dublin 221
Fairfield 186
Warsaw 134
Ashburn 109
Woodbridge 103
Cambridge 87
Ann Arbor 82
Jacksonville 80
Houston 76
Seattle 70
Wilmington 68
Singapore 67
Hong Kong 64
Princeton 40
Boston 34
Mumbai 31
Altamura 24
Melbourne 24
Lawrence 23
Boardman 20
Buffalo 20
Munich 17
Brussels 15
Falls Church 15
Florence 14
Medford 14
San Diego 12
Shanghai 12
Abidjan 11
Los Angeles 11
Dearborn 10
Izmir 10
Moscow 10
Beijing 8
Norwalk 8
New York 7
Washington 7
Andover 6
Hillsboro 5
Kent 5
Milan 5
Phoenix 5
Guangzhou 4
Ottawa 4
Toronto 4
Düsseldorf 3
Edinburgh 3
Frankfurt Am Main 3
Grafing 3
Lappeenranta 3
Rome 3
Romola 3
Verona 3
Algiers 2
Ascoli Piceno 2
Dong Ket 2
Frankfurt am Main 2
Groningen 2
Laurel 2
Naaldwijk 2
Philadelphia 2
Redwood City 2
Trento 2
Venezia 2
Yubileyny 2
Auburn Hills 1
Bacoli 1
Bend 1
Bologna 1
Budapest 1
Caserta 1
Central 1
Hanover 1
Helsinki 1
Jakarta 1
Kilburn 1
L'aquila 1
London 1
Osimo 1
Phnom Penh 1
Salerno 1
San Francisco 1
San Mateo 1
Suri 1
Tappahannock 1
Velletri 1
Xi'an 1
Yinchuan 1
Zagreb 1
Zurich 1
Totale 2.992
Nome #
The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR) 270
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 187
N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR) 174
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 150
ISOMERIC N,N-BIS(CYCLOHEXANOL)AMINE ARYL ESTERS: THE DISCOVERY OF A NEW CLASS OF HIGHLY POTENT P-GLYCOPROTEIN (PGP)-DEPENDENT MULTIDRUG RESISTANCE (MDR) INHIBITORS 149
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 146
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 143
2-PYRROLIDINONE MOIETY IS NOT CRITICAL FOR THE COGNITION ENHANCING ACTIVITY OF PIRACETAM-LIKE DRUGS 135
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators 135
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 129
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 125
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy 119
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 116
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs 113
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 109
N,N-bis(alkanol)amine aryl esters and N,N-bis(cyclohexanol)amine aryl esters: Idantification of a new class of Pgp-dependent multidrug resistance (MDR) reverters andowed with potencies in the nanomolar range 109
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 108
The Novel Potent Multidrug Resistance Inhibitors N,N-bis(cyclohexanol)amine Aryl Esters Are Devoid of Vascular Effects 104
Exploratory chemistry toward the identification of a new class of MDR reverters inspired by pervilleine and verapamil models 102
Rigid Analogs of DMPP As Probes For The Nicotinic Receptors 101
Inhibition of P-glycoprotein-mediated multidrug resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: structure-activity relationships 99
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 99
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 97
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 88
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 87
Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors 86
Design and synthesis of multidrug resistance (MDR) inhibitors 86
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic acid and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer 81
SAR studies in a series of N,N-bis(arylaLKANOL)AMINE ARYL ESTERS AS p-GLYCOPROTEIN (Pgp) dependent multidrug resistance (MDR) inhibitors 80
Isomeric N,N-(dicyclohexane-4-ol)amine aryl esters: the discovery of a new class of highly potent and efficacious Pgp-dependent MDR inhibitors 79
Exploratory Chemistry toward the identification of new classes of MDR reverters 77
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 74
Isomeric N,N-dicyclohexane-4-ol-amine aryl esters: the discovery of a new class of highly potent and efficacious Pgp-dependent MDR inhibitors 71
Isomeric N,N-dicyclohexane-4-ol-amine aryl esters: chemical and pharmacological development of highly potent and efficacious Pgp-dependent MDR inhibitors 70
Progettazione e sintesi di analoghi della Pervilleina A: una nuova classe di inibitori della Multidrug Resistance (MDR) 64
Nuovi modulatori della multidrug resistance (MDR) a struttura difenilcicloesilaminica 63
Multidrug resistance (MDR) modulators: Verapamil offsprings and heterocyclic derivatives 61
Sintesi chirale e valutazione farmacologica preliminare degli enantiomeri di DM232 e MC68, due azabiciclononanoni modulatori dei processi cognitivi 60
Optimization and structure-activity relationships of a new class of MDR reverters 50
Structure-activity relationships on N,N-dialkylaminoaryl esters, a new class of potent Pgp dependent multidrug resistance (MDR) inhibitors 48
Totale 4.244
Categoria #
all - tutte 10.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020199 0 0 0 0 0 0 45 54 37 25 30 8
2020/2021281 34 13 21 23 9 39 9 28 26 34 22 23
2021/2022292 11 37 29 11 8 8 14 15 9 8 71 71
2022/2023774 73 118 38 91 53 157 95 58 65 3 21 2
2023/2024297 16 28 40 12 7 89 8 66 3 3 9 16
2024/20251.673 65 175 118 245 643 427 0 0 0 0 0 0
Totale 4.244